On December 25, 2020, the Office of the National Medical Security Administration issued the "Notice on Accelerating the Implementation of the Pharmaceutical Price and Recruitment Credit Evaluation System", requiring all pharmaceutical companies to submit a letter of commitment to the recruitment platform. Starting from June 1, if other companies guarantee the supply or have alternatives to meet clinical needs for pharmaceutical products that have won the bid or are listed on the Internet, they should be removed from the Internet. In short, after June 1st, without submitting a letter of commitment, the product will be canceled from the Internet under the condition of ensuring the supply. Yesterday and today, Zhejiang, Hainan, Jiangxi, Shanxi and other provinces acted swiftly and issued notices to withdraw the network. Among them, the notice of withdrawal of the network in Jiangxi Province was shocking. The notice stated that, in accordance with the spirit of the relevant documents, Jiangxi Province, for pharmaceutical companies that have not submitted credit commitments, starting from 0:00 on June 1st, for pharmaceutical products that have won bids or are listed on the Internet, if there are other companies that guarantee the supply or have alternatives If the clinical needs are met, the platform will be removed from the network. Pharmaceutical companies and their products that have not submitted credit commitments will now be withdrawn from the Internet, and their online procurement and distribution qualifications will be suspended. The attachment shows that the list of companies that have not submitted credit commitments is as long as more than 3,400. Among them, Pfizer, AstraZeneca, Novartis, Otsuka, Merck, Merck and other well-known foreign pharmaceutical companies have been almost wiped out. Well-known domestic companies such as Ding and Lu Nan are also covered.
Fun Academic found that on May 10, Jiangxi Province issued the "Notice on Further Doing a Good Job in the Construction of the Pharmaceutical Price and Recruitment Credit Evaluation System", reminding and urging relevant pharmaceutical companies to submit a letter of commitment as soon as possible, otherwise starting from June 1. From the date onwards, the platform will be removed from the network if there are other companies that guarantee the supply of pharmaceutical products that have won the bid or are listed on the Internet or if there are alternatives to meet clinical needs. The attachment shows that there are more than 3,600 companies involved that have not submitted the letter of commitment. After an urgent reminder, from the final quantity, only more than 200 products submitted a letter of commitment. Comparing the list of withdrawals from Zhejiang, Hainan, Shanxi and other provinces, Quxue found that other provinces did not have such a large number of withdrawals as Shanxi, especially involving so many well-known pharmaceutical companies. In the notice, Jiangxi Province stated that all pharmaceutical companies, including manufacturing and operating companies, that are listed on the Internet in our province as bidders must submit a letter of credit undertaking in accordance with the regulations. If a national general agent is entrusted to bid for imported drugs, or a drug marketing authorization holder entrusts another company to bid, the national general agent and entrusted company shall be the bidders, and foreign companies and drug marketing authorization holders do not need to submit a letter of credit. According to the submission of credit commitments, the province will dynamically adjust the online procurement and distribution qualifications of relevant enterprises and their products.
Attachment: Corporate Commitment Letter (Yunnan version)
